Therefore, CCTG CO.26 is the first study to suggest that the combination of ICIs (anti-PD-L1 plus anti-CTLA-4) may prolong OS in patients with MSS-advanced CRC, especially in those with a high TMB [121]. Here, CD274 is linked to colorectal carcinoma.